🇺🇸 FDA
Patent

US 6569431

Recombinant antibody fragments as autoantibody antagonists

expired A61KA61K2039/505A61P

Quick answer

US patent 6569431 (Recombinant antibody fragments as autoantibody antagonists) held by The Regents of the University of California expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61P, A61P25/00, A61P37/02